#USA #Alimentiv #London, Ontario #Ultrasound Training #IBUS

Expanding Horizons in Clinical Trials: IUS-STAR Training Initiative

In a groundbreaking step towards enhancing clinical research in gastroenterology, Alimentiv Inc., a leading global clinical research organization specializing in gastrointestinal (GI) studies, has expanded its partnership with the International Bowel Ultrasound Group (IBUS). This collaboration aims to implement a structured training program for ultrasound in clinical trials, known as IUS-STAR (Intestinal Ultrasound Standardized Training and Acquisition for Research). This initiative is set to revolutionize how imaging is addressed in clinical trials involving inflammatory bowel disease (IBD).

A New Era of Ultrasound Training

The IUS-STAR program is a comprehensive training and certification initiative designed to provide sonographers, radiologists, and technologists with advanced education and skills necessary for performing intestinal ultrasounds (IUS) in clinical settings. The program combines e-learning modules with hands-on scanning practices, enabling participants to receive tailored feedback and build proficiency in delivering high-quality imaging relevant to clinical studies.

Stephanie Gonzalez, the Chief Operations Officer at Alimentiv, expressed her enthusiasm about the partnership, stating, "IUS-STAR exemplifies the strength of our collaboration, leveraging IBUS's scientific expertise with our global operational resources. This synergy enables quicker site setups and a wider array of IUS-ready locations for IBD trials."

In line with their mutual vision, the two organizations are committed to enhancing patient care through improved disease monitoring technologies. The structured training program ensures that clinical personnel are well-prepared, ultimately contributing to more efficient and effective research outcomes.

Commitment to Quality and Accessibility

As part of the program, participants will have opportunities to engage with expert reviewers, allowing them to gain insights through case reviews, constructive feedback sessions, and assessments leading to certification. This rigorous training ethos ensures that each operator develops the necessary skills to produce consistent and reliable ultrasound data, a critical requirement for the success of clinical trials.

Kerri Novak, President of IBUS, emphasized the significance of utilizing intestinal ultrasound as a non-invasive, repeatable tool for evaluating bowel conditions. She noted, "IUS is not just an imaging technique; it represents a significant leap forward in the clinical trial process. It improves patient accessibility and participation while enhancing our ability to assess disease activity and treatment responses."

Leading the Charge in Non-invasive Monitoring

The partnership between Alimentiv and IBUS marks a pivotal moment in the standardization of intestinal ultrasound in clinical research. Since their collaboration began in 2022, these organizations have successfully integrated advanced IUS practices in over 34 countries, setting a benchmark for non-invasive imaging modalities in IBD studies.

As the demand for noninvasive disease monitoring continues to surge, both Alimentiv and IBUS remain dedicated to fostering education, innovation, and quality assurance in the field of intestinal ultrasound. The launch of the IUS-STAR program reflects their commitment to improving the care of patients with gastrointestinal diseases.

For those interested in enhancing their expertise in IUS through this innovative training program, further information is available via the IBUS website or by contacting the team directly.

About Alimentiv and IBUS

Alimentiv has been a pioneering force in GI-focused clinical research for over 30 years, with a mission to advance therapeutic developments that enhance patient outcomes. With operations across North America, Europe, and beyond, Alimentiv brings comprehensive expertise to the clinical trial landscape.

The International Bowel Ultrasound Group is a non-profit organization comprising expert professionals dedicated to expanding the use of intestinal ultrasound among gastroenterologists and other specialists globally. They focus on advancing the education, research, and clinical applications of IUS to ultimately enhance patient care.

For more information, please visit Alimentiv's website and IBUS's website.